Delivery Order SPE2DB22D3010-SPE2DB25FP2HP
Award Date
4/30/25
Potential Completion Date
5/1/25
Potential Value
$2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with ID SPE2DB20D1100|SPE2DB25FB7Q8, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order for 4,567,942,388 units of the prescription medication Vyvanse 40 mg capsules, with a ceiling value of $3,798.80. This award is not set-aside and is a firm fixed-price contract. Amerisourcebergen Drug Corp is the prime contractor, and there is no mention of any subcontractors. The...
This federal contract award, valued at $2,670.10, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 4,568,058,061 units of the medication Vyvanse 40 mg capsules. The contract has an ultimate completion date of April 29, 2025 and is a firm fixed-price contract. This contract award is not associated with a set-aside program. Amerisourcebergen...
This federal contract award, with ID SPE2DB20D7061|SPE2DB25FSMV6, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $5,641.78 firm fixed-price delivery order is for the supply of 4,567,909,420 units of the medication Vyvanse 40 mg capsules. The contract has an ultimate completion date of April 11, 2025 and was awarded on April 10, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at...
This federal contract award, with ID SPE2DB24D1205|SPE2DB25FCWEW, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,568,058,212 units of Vyvanse 40 mg capsules, with a ceiling value of $2,290.97. This is a firm fixed-price delivery order contract with an ultimate completion date of April 29, 2025. The contract is not set aside for any specific business category. AmerisourceBergen Drug Corp,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $2,084.86 and is for the delivery of 4,566,526,084 units of the drug Vyvanse 40 mg capsules. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of November 25, 2024. This appears to be a task order under a larger Indefinite...
This federal contract award is for a delivery order from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,564,249,923 units of the prescription medication Vyvanse 40 mg capsules, with a ceiling value of $13,330.49. It has an ultimate completion date of April 10, 2024 and was awarded on April 9, 2024. The contract is a firm fixed-price delivery order and does not have a...
This federal contract award, with ID SPE2DB20D1051|SPE2DB25FD7SU, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,567,934,908 units of the medication Vyvanse 30 mg capsules. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,125.93 and an ultimate completion date of April 16, 2025. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp, the...
This federal contract award, valued at $2,079.94, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 4,568,076,036 units of the medication Vyvanse 40 mg capsules. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 30, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
This federal contract award, valued at $2,988.13, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order (SPE2DB20D1100|SPE2DB25FB6B4) for the supply of 4,567,850,772 units of the medication Vyvanse 40 mg capsules. The contract has an ultimate completion date of April 9, 2025 and is a firm fixed-price, non-set-aside contract. Amerisourcebergen Drug Corp holds a...
This federal contract award, with ID SPE2DB25D3012|SPE2DB25FWWUC, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,783.60 firm fixed-price delivery order is for the supply of 4,567,966 units of the prescription medication Vyvanse 40 mg capsules. The contract has an ultimate completion date of April 11, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract...